MBBS, MD General Medicine, DM Medical oncology, MRCP (Edin)
Educational Qualifications:
Completed MBBS from SV Medical College, Tirupati from 2006-2012.
Post-graduation in General Medicine, MD from Christian Medical College (CMC), Vellore (2013-2016).
Superspeciality training in Medical Oncology from Cancer Institute (WIA), Chennai (2017-2020).
MRCP (Royal College of Physicians, Edinburgh)
Training Courses
Essentials of Palliative care, Karunashraya, Bengaluru (2021)
Basic Course in Bio-medical Research- ICMR (2021)
Work Experience
Since October 2023: Consultant & Head – Medical Oncology, Sringeri Sharada Equitas Hospital, Chennai
2023: Consultant Medical Oncologist, Apollo Proton Cancer Centre, Chennai
2022-2023: Associate Consultant Medical Oncologist, Apollo Proton Cancer Centre, Chennai.
2020-2021: Assistant Professor, Department of Medical Oncology, SVIMS, Tirupati.
2016-2017: Senior Resident, Department of Medicine, AIIMS, New Delhi.
Publications & Presentations
Kumar DK, Radhakrishnan V. Efficacy And Toxicity Of Oral Metronomic Chemotherapy In Paediatric Solid Organ Malignacies-Experience From Tertiary Centre Over 8 Years. Pediatric Hematology Oncology Journal. 2018 Jan 1;3(3):S49.
Swamy A, Gogineni R, Ray A, Jha M, Manchanda S, Arava S, Kumar R, Kiran Kumar DVS, Sahu H, Ranjan P, Jadon RS. CRAB Manifestations in a Middle-Aged Female: A Diagnostic Dilemma. Journal of The Association of Physicians of India. 2018 Jan;66:86.
Kiran Kumar DVS. Incidence, risk factors and complications of dysphagia in stroke patients admitted to medical wards at a tertiary hospital in South India (Doctoral dissertation, Christian Medical College, Vellore).
Kiran Kumar DVS, Perumal Kalaiyarasi J. Drawback of chimerism analysis by XYfluorescence in situ hybridization: Deception of a relapse. Indian J Med Paediatr Oncol 2020;41:621-3.
Kumar K, Radhakrishnan V, Dhanushkodi M, Kalaiyarasi JP, Mehra N, Kumar AR, et al. Oral etoposide and cyclophosphamide: A low-cost palliative metronomic chemotherapy in advanced pediatric cancers. Cancer Res Stat Treat 2020;3:648.
Oral presentation titled ‘treatment related necrosis in glioma: clinical and MRI based radiological responses with bevacizumab’ in ISO-ISMPO National conference 2022.
Oral presentation titled ‘Concurrent Pazopanib with Radiotherapy- Early experience from a tertiary care centre' at ISO-ISMPO National conference 2022.
Oral presentation titled ‘ACCESS STUDY- perception among professionals in oncopharmacy industry about access to targeted/immunotherapy drugs’ in ISO-ISMPO National conference 2022.
Presented in ASCO 2023- Phase 3 randomized controlled trial comparing the effectiveness of dexamethasone in reducing cancer-associated fatigue in patients on palliative chemotherapy.
.svg
){kind=small}
.svg
){kind=small}
.svg){kind=small}
